InFLUenza and the HEART An Investigation Into the Acute and Lasting Cardiac Effects of Influenza Infection
NCT ID: NCT05084846
Last Updated: 2023-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2022-01-01
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vaccination Against Influenza Pre-discharge in Heart Failure
NCT06725927
Respiratory Virus Infections in Acute Heart Failure
NCT06967441
Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.
NCT06259487
A Survey to Assess Effects of Covid-19 on Cardiovascular Patients
NCT04508920
Flu Vaccination in Congestive Heart Failure
NCT00664339
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \> 18 years of age
Exclusion Criteria
* Persons unable to understand and sign "informed consent"
* Pregnancy
* Persons simultaneously positive with COVID-19
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Gentofte, Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tor Biering-Sørensen
Associate Professor and Research Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Herlev & Gentofte Hospital
Copenhagen, , Denmark
Cardiovascular Non-Invasive Imaging Research Laboratory, department of Cardiology, Herlev & Gentofte Hospital
Hellerup, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Tor Biering-Sørensen, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Tor Biering-sørensen, MD, PhD, MPH
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-21011835
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.